The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study

Overview of attention for article published in Critical Reviews in Diagnostic Imaging, June 2009

Altmetric Badge

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 69 Dimensions

Readers on

mendeley: 43 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Deferiprone

Cited by Canadian Agency for Drugs and Technologies in Health on 05 Oct 2018

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.